Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing
This study was performed to determine whether adult male patients with Fabry disease who demonstrate a continuing decline in renal function despite 2 to 4 yr of conventionally dosed agalsidase alfa therapy (0.2 mg/kg every other week [EOW]) show an improved slope of decline with weekly administratio...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2007
|
| In: |
Journal of the American Society of Nephrology
Year: 2007, Jahrgang: 18, Heft: 5, Pages: 1576-1583 |
| ISSN: | 1533-3450 |
| DOI: | 10.1681/ASN.2006111263 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1681/ASN.2006111263 Verlag, Volltext: https://jasn.asnjournals.org/content/18/5/1576 
|
| Verfasserangaben: | Raphael Schiffmann, Hasan Askari, Margaret Timmons, Chevalia Robinson, William Benko, Roscoe O. Brady, and Markus Ries |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665088737 | ||
| 003 | DE-627 | ||
| 005 | 20230426130921.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190509s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1681/ASN.2006111263 |2 doi | |
| 035 | |a (DE-627)1665088737 | ||
| 035 | |a (DE-599)KXP1665088737 | ||
| 035 | |a (OCoLC)1341212883 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schiffmann, Raphael |e VerfasserIn |0 (DE-588)111475126X |0 (DE-627)869019376 |0 (DE-576)477474578 |4 aut | |
| 245 | 1 | 0 | |a Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing |c Raphael Schiffmann, Hasan Askari, Margaret Timmons, Chevalia Robinson, William Benko, Roscoe O. Brady, and Markus Ries |
| 264 | 1 | |c May 2007 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.05.2019 | ||
| 520 | |a This study was performed to determine whether adult male patients with Fabry disease who demonstrate a continuing decline in renal function despite 2 to 4 yr of conventionally dosed agalsidase alfa therapy (0.2 mg/kg every other week [EOW]) show an improved slope of decline with weekly administration using the same dosage. Eleven (27%) of 41 adult male patients with Fabry disease who participated in long-term agalsidase alfa clinical trials and who had demonstrated a slope of decline in estimated GFR (eGFR) of ≥5 ml/min per 1.73 m2/yr while receiving long-term treatment with agalsidase alfa at the currently recommended dosage of 0.2 mg/kg, infused EOW, were enrolled in this open-label, prospective study. Patients were switched from EOW to weekly infusions and followed for an additional 24 mo. Before switching to weekly dosing, eGFR was 53.7 ± 6.3 ml/min per 1.73 m2 (mean ± SEM), and mean rate of change in eGFR was −8.0 ± 0.8 ml/min per 1.73 m2/yr. During the 24-mo follow-up period after switching to weekly dosing, the mean rate of change in eGFR was observed to slow to −3.3 ± 1.4 ml/min/1.73 m2/yr (P = 0.01 versus EOW). After switching to weekly dosing, three patients demonstrated an improvement in eGFR and six patients demonstrated a slowing in the rate of eGFR decline; only two patients failed to improve their eGFR slope. A multiple regression model confirmed that the weekly infusion regimen was the strongest explanatory variable for the change in eGFR (P = 0.0008), with a weaker contribution from the concomitant use of angiotensin converting enzyme inhibitors/angiotensin receptor blockers (P = 0.02). These results suggest that weekly infusions of agalsidase alfa at a dosage of 0.2 mg/kg may be beneficial in the subgroup of patients who have Fabry disease and whose kidney function continues to decline after 2 to 4 yr or more of standard EOW dosing. | ||
| 700 | 1 | |a Ries, Markus |d 1971- |e VerfasserIn |0 (DE-588)136385338 |0 (DE-627)582068479 |0 (DE-576)300993358 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Society of Nephrology |t Journal of the American Society of Nephrology |d Washington, DC : American Society of Nephrology, 1990 |g 18(2007), 5, Seite 1576-1583 |h Online-Ressource |w (DE-627)324616481 |w (DE-600)2029124-3 |w (DE-576)094113769 |x 1533-3450 |7 nnas |
| 773 | 1 | 8 | |g volume:18 |g year:2007 |g number:5 |g pages:1576-1583 |g extent:8 |a Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing |
| 856 | 4 | 0 | |u https://doi.org/10.1681/ASN.2006111263 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://jasn.asnjournals.org/content/18/5/1576 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190509 | ||
| 993 | |a Article | ||
| 994 | |a 2007 | ||
| 998 | |g 136385338 |a Ries, Markus |m 136385338:Ries, Markus |p 7 |y j | ||
| 999 | |a KXP-PPN1665088737 |e 3473561657 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1665088737","title":[{"title_sort":"Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing","title":"Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing"}],"id":{"doi":["10.1681/ASN.2006111263"],"eki":["1665088737"]},"note":["Gesehen am 09.05.2019"],"origin":[{"dateIssuedKey":"2007","dateIssuedDisp":"May 2007"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"8 S."}],"person":[{"display":"Schiffmann, Raphael","role":"aut","given":"Raphael","family":"Schiffmann","roleDisplay":"VerfasserIn"},{"family":"Ries","roleDisplay":"VerfasserIn","role":"aut","display":"Ries, Markus","given":"Markus"}],"name":{"displayForm":["Raphael Schiffmann, Hasan Askari, Margaret Timmons, Chevalia Robinson, William Benko, Roscoe O. Brady, and Markus Ries"]},"relHost":[{"id":{"issn":["1533-3450"],"eki":["324616481"],"zdb":["2029124-3"]},"title":[{"subtitle":"JASN","title":"Journal of the American Society of Nephrology","title_sort":"Journal of the American Society of Nephrology"}],"disp":"American Society of NephrologyJournal of the American Society of Nephrology","note":["Gesehen am 19.08.24"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"5","volume":"18","text":"18(2007), 5, Seite 1576-1583","pages":"1576-1583","extent":"8","year":"2007"},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"American Society of Nephrology ; Ovid","dateIssuedDisp":"1990-","dateIssuedKey":"1990","publisherPlace":"Washington, DC ; [Erscheinungsort nicht ermittelbar]"}],"language":["eng"],"titleAlt":[{"title":"JASN"}],"pubHistory":["1.1990 -"],"corporate":[{"display":"American Society of Nephrology","role":"aut","roleDisplay":"VerfasserIn"}],"recId":"324616481"}]} | ||
| SRT | |a SCHIFFMANNWEEKLYENZY2007 | ||